PTK2, protein tyrosine kinase 2, 5747

N. diseases: 205; N. variants: 21
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0155626
Disease: Acute myocardial infarction
Acute myocardial infarction
0.010 Biomarker disease BEFREE Our novel findings show the effects of periostin on recruitment of activated fibroblasts through FAK-integrin signaling and on their collagen fibril formation specific to healing after AMI. 18208976 2008
CUI: C0001418
Disease: Adenocarcinoma
Adenocarcinoma
0.030 AlteredExpression group BEFREE The latter mechano-regulatory circuit was also observed in TAFs but in a subtype-specific fashion, because SCC-TAFs exhibited higher FAK (pY397), β1 expression, and ERK1/2 (pT202/Y204) than ADC-TAFs. 25280968 2015
CUI: C0001418
Disease: Adenocarcinoma
Adenocarcinoma
0.030 Biomarker group LHGDN FAK and IGF-IR interact to provide survival signals in human pancreatic adenocarcinoma cells. 18263593 2008
CUI: C0001418
Disease: Adenocarcinoma
Adenocarcinoma
0.030 AlteredExpression group BEFREE To determine the role of elevated FAK expression in facilitating epidermal growth factor (EGF)-stimulated human adenocarcinoma (A549) cell motility, antisense oligonucleotides were used to reduce FAK protein expression >75%. 11585739 2001
CUI: C1319315
Disease: Adenocarcinoma of large intestine
Adenocarcinoma of large intestine
0.010 AlteredExpression disease BEFREE The present study aimed to assess FAK/Src/PXN protein expression in both primary and liver metastatic sites of colorectal adenocarcinoma (CRC). 29135089 2019
CUI: C0152013
Disease: Adenocarcinoma of lung (disorder)
Adenocarcinoma of lung (disorder)
0.020 AlteredExpression disease BEFREE Expression of c-MET and FAK in lung adenocarcinoma cells was also reduced by ACTA2-targeting siRNAs and shRNAs, and was accompanied by a loss of mesenchymal characteristics. 23995859 2013
CUI: C0152013
Disease: Adenocarcinoma of lung (disorder)
Adenocarcinoma of lung (disorder)
0.020 GeneticVariation disease BEFREE We evaluated the impact of <i>Nf1</i> loss on LUAD development using a CRISPR/Cas9 platform in a murine model of <i>Kras</i>-mutant LUAD We discovered that <i>Nf1</i> deactivation is associated with Fak1 hyperactivation and phosphoserine aminotransferase 1 (Psat1) upregulation in mice. 31036704 2019
CUI: C0281361
Disease: Adenocarcinoma of pancreas
Adenocarcinoma of pancreas
0.010 PosttranslationalModification disease BEFREE FAK gene silencing suppresses anoikis resistance in pancreatic adenocarcinoma cells. 15118593 2004
CUI: C0001430
Disease: Adenoma
Adenoma
0.010 AlteredExpression group BEFREE In addition, in an in vitro model for human colon cancer progression there was a copy number gain of the fak gene during conversion from adenoma to carcinoma, which was associated with increased pp125FAK protein expression. 10523844 1999
CUI: C1332183
Disease: Adult Astrocytic Tumor
Adult Astrocytic Tumor
0.010 AlteredExpression disease BEFREE Compared to normal brain, the expression of p125FAK was elevated in malignant astrocytic tumor biopsies from patient samples. 11069767 2000
CUI: C0278595
Disease: Adult Fibrosarcoma
Adult Fibrosarcoma
0.010 Biomarker disease BEFREE The utilization of FAK‑deficient cells demonstrated that the participation of FAK was obligatory for heparin‑dependent fibrosarcoma cell adhesion (p<0.05). 27572115 2016
CUI: C0278878
Disease: Adult Glioblastoma
Adult Glioblastoma
0.040 Biomarker disease BEFREE Thus, microarray gene expression analysis can be effective in establishing genes affected in response to FAK inhibitor alone and in response to combination of Y15 with temozolomide that is important for glioblastoma therapy. 23387973 2014
CUI: C0278878
Disease: Adult Glioblastoma
Adult Glioblastoma
0.040 AlteredExpression disease BEFREE In this report, we found that naringin can specifically inhibit the kinase activity of FAK and suppress the FAK<sup>p-Try397</sup>and its downstream pathway in glioblastoma cells. 27125297 2017
CUI: C0278878
Disease: Adult Glioblastoma
Adult Glioblastoma
0.040 Biomarker disease BEFREE Also, knockdown- or pharmacological agent-based attenuation of EGFR, FAK or Graf (ARHGAP26)/small GTPase-mediated pathways markedly mitigated the aggressiveness of glioblastoma cells. 26377974 2015
CUI: C0278878
Disease: Adult Glioblastoma
Adult Glioblastoma
0.040 PosttranslationalModification disease BEFREE Moreover, the dimeric bicyclic ligand induced cell detachment and inhibited FAK phosphorylation in U-373 MG glioblastoma cells. 31556442 2019
CUI: C0278608
Disease: Adult Liposarcoma
Adult Liposarcoma
0.010 Biomarker disease BEFREE Screening assays identified several previously unrecognized targets including PTK2 and KIT in liposarcoma. 29132397 2017
CUI: C0220630
Disease: Adult Liver Carcinoma
Adult Liver Carcinoma
0.020 Biomarker disease BEFREE Thyroid hormone-mediated regulation of lipocalin 2 through the Met/FAK pathway in liver cancer. 25940797 2015
CUI: C0220630
Disease: Adult Liver Carcinoma
Adult Liver Carcinoma
0.020 AlteredExpression disease BEFREE The expression of DLC1 and p-FAK Y397 were negatively correlated. 22272086 2011
CUI: C1332206
Disease: Adult Lymphoma
Adult Lymphoma
0.010 AlteredExpression disease BEFREE A basal state of pp125FAK tyrosine phosphorylation was observed in T and B lymphocytes, and its expression level was in general augmented among human T- and B-cell leukemia/lymphoma lines. 7692878 1993
CUI: C0278877
Disease: Adult Meningioma
Adult Meningioma
0.010 Biomarker disease BEFREE In addition, total and phosphorylated AKT, ERK, and FAK, which have been shown to be important drivers for meningioma cell proliferation, were markedly lower in silvestrol-treated Ben-Men-1 cells. 28610844 2018
ANOPHTHALMIA AND PULMONARY HYPOPLASIA
0.010 Biomarker disease BEFREE Further studies revealed that SRPX2 expression in PDAC tissues significantly correlated with the phosphorylation levels of FAK, indicating that FAK dependent pathway may be account for the effect of SRPX2 on cell migration and invasion in PDAC. 26191169 2015
CUI: C0004096
Disease: Asthma
Asthma
0.010 Biomarker disease BEFREE Peptide *CRRETAWAC* antagonizes fibronectin-induced cytokine synthesis and secretion of airway smooth muscle cells via the inhibition of FAK and p38 MAPK, and is a potential agent for the therapy of asthma. 28402030 2017
CUI: C0004114
Disease: Astrocytoma
Astrocytoma
0.020 PosttranslationalModification disease BEFREE Finally, we analyzed the effects of intermediate filament gene transfer on FAK phosphorylation in SF-126 astrocytoma cells. 10029102 1999
CUI: C0004114
Disease: Astrocytoma
Astrocytoma
0.020 AlteredExpression disease BEFREE Compared to normal brain, the expression of p125FAK was elevated in malignant astrocytic tumor biopsies from patient samples. 11069767 2000
CUI: C0004238
Disease: Atrial Fibrillation
Atrial Fibrillation
0.400 Biomarker disease CTD_human Multi-ethnic genome-wide association study for atrial fibrillation. 29892015 2018